Background: IscU populates structured (S) and disordered (D) conformational states. In Fe-S cluster delivery, IscU interacts with HscB and HscA. Results: NMR reveals differential interactions of the S-and D-states with HscA and HscB. Conclusion: HscA and HscA-ADP bind preferentially to the D-state. HscB binds preferentially to the S-state. HscA-ATP binds neither the S-nor D-state tightly. Significance: Fe-S cluster transfer is coupled to chaperone-mediated disordering of IscU.
Fe-S clusters play key roles in all forms of life in functions as diverse as electron transport, enzyme activity, and environmental sensing. In the Fe-S cluster system for Fe-S cluster biosynthesis and delivery, which is conserved from prokaryotes (1) to the mitochondria of eukaryotes (2), Fe-S clusters are assembled on the scaffold protein IscU and are transferred to acceptor proteins through the agency of HscB, a J-protein co-chaperone, and HscA, a specialized Hsp70 chaperone (3) . Cluster transfer involves ATP hydrolysis catalyzed by HscA attended by a change in the conformation of HscA (4) . It is known that IscU and HscB bind to HscA and enhance its ATPase activity. However, the details of how these interactions are coupled to cluster transfer remain to be discovered.
Although IscU by itself has cluster transfer activity (5), the transfer rates are greatly stimulated in the presence of HscA, HscB, and MgATP (4) . This indicates that HscA and HscB are required for efficient cluster transfer in vivo. It is intriguing that HscA and HscB are specifically used for Fe-S cluster transfer despite their high sequence identities to members of the Hsp70 and Hsp40 protein families: DnaK and DnaJ, respectively (6) . As with other members of the Hsp70 and Hsp40 families, HscA has intrinsic ATPase activity, and this activity is greatly stimulated both by its protein substrate IscU and by HscB (7) . In particular, the L 99 PPVK 103 (Escherichia coli numbering) motif of IscU is recognized by HscA. The isolated nonapeptide E 98 LPPVKIHC 106 is sufficient to stimulate the ATPase activity of HscA as much as full-length IscU (8, 9) . HscA has two domains: the nucleotidebinding domain and the substrate-binding domain (SBD). 2 Nucleotide binding to the nucleotide-binding domain allosterically regulates the affinity of SBD for IscU (7) . The dissociation constant for apo-IscU bound to HscA-ATP is 37 M, whereas it is 9 M for apo-IscU bound to HscA-ADP (10) . As with Hsp40 proteins, HscB has an N-terminal J-domain that interacts with HscA by a highly conserved His-Pro-Asp motif and a C-terminal domain that binds IscU (11, 12) . The dissociation constant between HscB and apo-IscU was reported to be ϳ13 M (11) .
The discovery of a disease caused by an intronic mutation in the human ISCU gene (13, 14) has demonstrated the critical role of the scaffold protein (IscU) encoded by this gene. More recently, it was found that complete knock-out of the Iscu gene in mice results in early embryonic death (15) .
We have shown that apo-IscU populates two interconverting conformational states, a disordered (D) state and a structured (S) state, and that interaction with HscB shifts the D^S equilibrium toward the S-state (16) . The structure of the S-state resembles that adopted by IscU when it contains either a [2Fe-2S] cluster (17) or Zn 2ϩ ion (18) , whereas the D-state appears not to interact with metal ions (19) . We report here that the addition of a substoichiometric quantity of HscA decreases the D 3 S rate while not affecting the S 3 D rate, thus shifting the D^S equilibrium toward the D-state. In the presence of excess HscA or the HscA-ADP complex, IscU becomes transformed to a D-like state. By contrast, a variant of IscU that exists predominantly in the S-state (N90A) and the IscU-Zn 2ϩ complex that is fully in the S-state (19) are each only partially converted to the D-like state upon the addition of HscA. These results suggest that HscA, alone or as the ADP complex, binds to and stabilizes the D-state of IscU. The addition of ATP to the IscU-HscA complex causes release of IscU, which then resumes the D^S equilibrium. We propose a mechanism (Fig. 1 ) consistent with these findings in which cluster transfer from IscU is coupled to hydrolysis of HscA-bound ATP and the concomitant conformational change that enables HscA-ADP to bind and stabilize the D-state of IscU, which promotes both the release of the Fe-S cluster to an acceptor protein and the release of HscB.
EXPERIMENTAL PROCEDURES

Production and Purification of Proteins-HscB, [U-
15 N]apoIscU, and [U- 13 C, 15 N]apo-IscU were prepared as described previously (11, 16 First, a single colony of transformed BL21 competent cells (Novagen) was transferred to 5 ml of LB medium containing 100 g/ml ampicillin and incubated for ϳ8 h at 37°C. From this, a 0.1-ml inoculum was transferred to 5 ml of M9 minimal medium supplemented with 100 g/ml ampicillin, 1 g/liter NH 4 Cl, and 5 g/liter glucose. The cells were adapted to growth in D 2 O by stepwise growths of 0.1-ml inoculants in 5 ml of M9 medium dissolved in 20, 50, 80, and 100% D 2 O, respectively; each cell growth was incubated for 8 -12 h at 37°C. A 0.1-ml inoculant from 5 ml of 100% D 2 O/M9 medium was transferred to 50 ml of 100% D 2 O/M9 medium, which was incubated for ϳ20 h at 37°C. The cell pellet harvested from 50 ml of medium was finally transferred to 500 ml of 100% D 2 O/M9 medium supplemented with 100 g/ml ampicillin, 1 g/liter 15 NH 4 Cl, and 5 g/liter glucose. Overexpression was induced by the addition of 0.4 mM isopropyl ␤-D-thiogalactopyranoside at A 600 Ϸ 0.8, followed by further incubation for 6 -8 h at 37°C. This procedure, which leads to the deuteration of most H ␣ and H ␤ positions, results in significant increases in the intensities of 1 H N signals from larger macromolecules (20) . Harvested cell pellets were stored at Ϫ80°C until used.
The expression plasmids for full-length WT HscA and the HscA SBD (residues 389 -616) were generous gifts from Dr. Larry E. Vickery (University of California, Irvine). The expression plasmid for HscA(T212V) was created by applying the QuikChange II site-directed mutagenesis kit (Stratagene) to the WT HscA expression vector. Full-length HscA and the HscA SBD were produced by procedures described previously (21, 22) . The cycle initiates with recruitment of the complex between HscB (green) and Fe-S cluster-bound IscU (IscU, red; Fe-S cluster, orange) to ATP-bound HscA (T-state; tan). An acceptor protein, represented here by ferredoxin (maroon), attacks the cluster, leading to hydrolysis of ATP and a concomitant conformational change in ADP-bound HscA (R-state; purple), which stabilizes the disordered form of IscU. Disordering of IscU leads to release of the cluster and HscB. Disordered IscU remains bound to HscA after release of ADP, but subsequent binding of ATP changes the conformation of HscA to the T-state, which releases apo-IscU. This scheme incorporates the findings reported here into earlier mechanisms (4, 7) . Specifically, the current mechanism shows cluster transfer coupled to attack by the acceptor protein, ATP hydrolysis, the T-to-R conformational change of HscA, and the conversion of IscU from the S-to D-state, with release of the cluster and HscB.
Full-length HscA and the HscA SBD were purified by procedures described previously (21, 22) , except for the use of anionexchange chromatography and size-exclusion chromatography instead of reversed-phase chromatography. For the additional anion-exchange chromatography step, a DEAE Bio-Gel column (Bio-Rad) was used with a 0 -0.15 M NaCl gradient. Size-exclusion chromatography was accomplished with a HiLoad 16/60 Superdex 200 column (GE Healthcare) for full-length HscA or with a HiLoad 16/60 Superdex 75 column (GE Healthcare) for the HscA SBD. The elution buffer for this step consisted of 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 0.5 mM EDTA, and 150 mM NaCl.
NMR Spectroscopy-The solvent used for NMR samples contained either 50 mM HEPES/NaOH (pH 7.3), 10 mM MgCl 2 , 150 mM KCl, and 5 mM DTT (HMKD buffer) or 50 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, and 5 mM DTT (TED buffer) with 7% D 2 O, 0.7 mM 2,2-dimethyl-2-silapentane-5-sulfonate, and 0.02% sodium azide. All NMR spectra were acquired on 600-or 900-MHz Varian VNMRS spectrometers equipped with a z-gradient cryogenic probe. Sample temperatures were maintained at 25°C. NMRPipe (23) was used to process the raw NMR data; SPARKY (24) was used for data analysis; and the Newton software package (25) was used to determine peak volumes and their ratios.
The titration experiments of IscU and IscU(N90A) were initiated with 0.3 mM [U-
15 N]apo-IscU samples in HMKD buffer, and these samples were subsequently mixed with 1 or 2 eq of unlabeled full-length HscA or the HscA SBD. A two-dimensional 15 N transverse relaxation optimized spectroscopy-heteronuclear single quantum correlation (TROSY-HSQC) spectrum of each mixture was collected. For the titration experiment with WT IscU-Zn 2ϩ , the complex was prepared by adding ZnCl 2 (final concentration of 1 mM) to the protein sample. The chemical shift perturbation of apo-IscU upon interacting with HscA was investigated by titrating [U- 13 N TROSY-HSQC, three-dimensional HNCO, three-dimensional HN(CO) CA, and three-dimensional HNCACB spectra with reference to assigned chemical shifts of the D-state of IscU (19) .
The conformational exchange rates of apo-IscU were measured by two-dimensional NMR exchange spectroscopy (26) . To achieve this, we prepared samples containing 0.35 mM [U-
15 N]apo-IscU in TED buffer alone and in the presence of a substoichiometric amount (0.09 mM) of added HscA. Two-dimensional N z exchange 15 N HSQC spectra were collected for each sample with a series of mixing times: 0, 20, 40, 60, 80, 100, 200, and 300 ms. The rates of the conformational transition were estimated from the initial slopes of the exchange crosspeak volumes normalized by the diagonal peak volumes as a function of the mixing time (Յ200 ms) (26) . No exchange crosspeaks were observed with mixing times of 0 and 20 ms, whereas with mixing times longer than 200 ms, the slopes were no longer linear as the result of relaxation effects. Previous NMR peak assignments to residues of apo-IscU in the S-and D-states (19) were used in obtaining residue-specific exchange rates. The experiments were repeated twice with two independently prepared samples to estimate errors from S.D.
Determination N TROSY-HSQC spectra of each mixture. Nucleotide exchange on HscA has been shown to be fast and not to require an exchange factor (27) . As a model for HscA bound to ATP, we used the HscA(T212V)-ATP complex because this variant exhibits negligible (if any) ATPase activity, yet it undergoes the nucleotideinduced conformational transition (28 -30) .
RESULTS
HscA Binds and Stabilizes the Disordered State of Apo-IscU-
To determine whether HscA interacts preferentially with the Sor D-state of IscU, we used two-dimensional 1 H- 15 N exchange spectroscopy to compare the S 3 D and D 3 S conformational exchange rates of [U-
15 N]apo-IscU in the absence and presence of substoichiometric HscA. In this experiment, the exchange peak horizontal to the S diagonal peak reports on the S 3 D reaction, and the exchange peak horizontal to the D diagonal peak reports on the D 3 S reaction ( Fig. 2A) . We measured the ratio of the cross-peak to the diagonal as a function of the mixing time of the experiment and determined the rate from the initial slope before exchange became obscured by relaxation effects (Fig. 2B) (26) . We found that the addition of 0.25 eq of HscA reduced the D 3 S rate by a factor of ϳ2 (Fig. 2B , lower panels), whereas the S 3 D rate was unaffected within experimental error (Fig. 2B, upper panels) . The addition of ADP did not induce further change in the exchange rate of IscU (data not shown). This result suggests that HscA preferentially interacts with and stabilizes the D-state of apo-IscU.
We used two-dimensional 15 N TROSY-HSQC spectroscopy to follow the titration of a sample of [U-
15 N]apo-IscU with increasing amounts of unlabeled HscA. Before the addition of HscA, the spectrum (Fig. 3A) exhibited sets of peaks corresponding to those assigned to the S-and D-states of IscU (16, 19) . Upon the addition of HscA, the peaks corresponding to the S-state decreased progressively and had nearly disappeared at a level of 2 eq of unlabeled HscA/eq of 15 N-labeled IscU; only peaks corresponding to a D-like state remained (Fig. 3B) . The subsequent addition of 2 eq of unlabeled IscU led to partial recovery of signals corresponding to the S-state (Fig. 3C) as the result of displacing some of the 15 N-labeled IscU from the IscUHscA complex; this result shows that the IscU-HscA interaction is reversible and that the observed effects were not the result of an artifact such as irreversible protein denaturation or proteolysis. The side chain 1 H-15 N of Trp-76 (the only tryptophan residue in IscU) exhibited separate two-dimensional NMR cross-peaks for the S-and D-states (Fig. 3, A and D, upper  panel) . Upon formation of the IscU-HscA complex, the signals assigned to the S-and D-states decreased in intensity, and a new peak grew in intensity at an intermediate position (Fig. 3D, mid We were able to assign a large number of backbone signals in spectra of the IscU-HscA complex by collecting three-dimensional HNCO spectra of [U-13 C, 15 N]apo-IscU as a function of added HscA (Fig. 4A) . These assignments, which we have deposited in the Biological Magnetic Resonance Data Bank (accession number 18381), enabled us to compare the chemical shifts of the 1 H-15 N backbone signals of the IscU-HscA complex with those assigned to the S-and D-states of apo-IscU alone (19) . We found that the signals from the complex closely resembled those of the free D-state. This is illustrated in Fig. 4B , Fig. 4B ) broadened as HscA was added and were no longer detected after the addition of a stoichiometric amount of HscA. The broadening likely arises from residues becoming immobilized by binding to HscA, and this conclusion is reinforced by the fact that several of the broadened signals correspond to residues flanking the L 99 PPVK 103 motif of IscU, which is known to interact with HscA (8, 9, 22) . Chemical shift analysis of the assigned signals from IscU complexed with HscA showed that the protein lacks secondary structure (Fig. 4C) . From these results, we conclude that the conformation of IscU bound to HscA closely resembles that of the D-state of free apo-IscU, which is dynamically disordered and exhibits no secondary structural elements (19) . To illustrate this, on the threedimensional structure of the S-state of IscU (Fig. 4D) , residues of IscU shown to be disordered in the IscU-HscA complex are colored green, and residues whose signals broadened in the IscU-HscA complex are colored red; residues shaded black are ones whose signals were not observed in the spectrum of free IscU.
Because the S-state of apo-IscU is known to be stabilized by the N90A substitution (19) or by the addition of Zn 2ϩ (16, 19) , we investigated the effects of adding HscA on the conformations of these two proteins. In comparison with wild-type IscU, much more of the S-state remained after the addition of 2 eq of HscA to [U- 15 The straight lines represent the initial slopes, which yield the rates. The peaks studied were chosen because they were not overlapped by other signals. Both cross-peaks and diagonals were observable for Asn-26, but only single cross-peaks and diagonals were observable for the other residues. The agreement of the measured rates within experimental error is consistent with a two-state reaction. In the absence of HscA (wo HscA; blue triangles), the S 3 D (upper panels) exchange rates were 0. interact strongly with the S-state of IscU and that the S 3 D equilibrium must be perturbed to the D-state to form the complex. DnaK (31, 32) and the x-ray structure of the HscA SBD complexed with the nonapeptide E 98 LPPVKIHC 106 (22) have shown that that the isolated SBD binds its substrate. We carried out titration experiments similar to those described above, but with the HscA SBD in place of full-length HscA and with [U- 15 (Fig. 5) . The addition of 2 eq of the HscA SBD led to the disappearance of the S-state peaks of apo-IscU. We conclude that the HscA SBD, like full-length HscA, binds to and stabilizes a D-like state of IscU. With the smaller complex containing fractionally deuterated IscU, we were able to resolve a few peaks (indicated by arrows in Fig. 5 ) that appear likely to correspond to residues of IscU directly involved in the binding interface. (Fig. 6A) . Although Lys-128 is located in the disordered C-terminal region of IscU, it nonetheless exhibits separate peaks corresponding to the S-and D-states of apo-IscU. In addition, because the residue is located in a highly disordered region, the intensities of its signals are minimally affected by the molecular size of the complex; and from its location and poor sequence conservation (16) , it is unlikely that Lys-128 is involved in interactions with HscB or HscA. We measured the volumes of the peaks assigned to the S-and D-states under a variety of conditions and used these to calculate the following: (Fig. 6B) . %S Ϸ 84 for 0.3 mM IscU alone. Upon the addition of equimolar HscB, %S increased to 93. Equimolar IscU ϩ HscA had %S ϭ 51, as did equimolar IscU ϩ HscA-ADP. Equimolar IscU ϩ HscA(T212V) in the absence or presence of ADP yielded %S ϭ 47. %S increased to 51 for IscU ϩ HscA(T212V) ϩ ATP. Equimolar IscU ϩ HscB ϩ HscA had %S ϭ 60. This value remained about the same when wild-type HscA was substituted by HscA(T212V) or when ADP was added to equimolar IscU ϩ HscB ϩ HscA(T212V). However, %S increased to a value similar to that for IscU alone when ADP in the previous mixture was replaced by ATP. We used HscA(T212V), which lacks ATPase activity, as a surrogate for HscA in this experiment because the addition of IscU to HscA-ATP led to rapid ATP hydrolysis (data not shown).
HscA SBD Preferentially Binds and Stabilizes the D-state of Apo-IscU-Studies of E. coli
Summary of Effects of Protein and Ligand
These results confirmed our earlier finding that HscB binds preferentially to the S-state of IscU (16) . The stabilizing effect of HscB is negated by HscA, which interacts preferentially with the D-state both alone and in its ADP complex. As noted above, the results establish that HscA-ATP fails to interact preferentially with either state of IscU.
DISCUSSION
An earlier model (30) postulated that cluster transfer occurs following the exchange of ADP with ATP, leading to release of holo-IscU from HscA. The results presented here show that cluster transfer instead is coupled to the hydrolysis of ATP bound to HscA with conversion of HscA from the T-state to the R-state, which binds IscU (Fig. 1) . HscA-ADP binds to the D-state of IscU, and IscU in the complex is disordered and incapable of retaining the Fe-S cluster.
The results presented here, along with those published earlier (16) In the IscU-[2Fe-2S] complex, the side chains of His-105 and Cys-106 ligate different iron atoms, and the backbone conformation of the recognition peptide (E 98 LPPVKIHC 106 ) is very different from its conformation when complexed to the HscA SBD (22) . We found that, when bound to HscA, IscU residues flanking the recognition peptide exhibited NMR chemical shifts very similar to those of the D-state of IscU (Fig. 4) . We conclude that IscU must undergo the S 3 D conversion to interact with HscA.
We speculate here that the attack of cysteinyl side chains from an acceptor protein on iron atoms of the IscU-bound Fe-S cluster is the event that triggers both ATP hydrolysis and the disordering of the recognition peptide that allows it to bind to HscA-ADP. In a possible scenario, which has yet to be tested, attack of two Cys residues from the acceptor protein on the two iron atoms of the [2Fe-2S] cluster displaces IscU ligands His-105 and Cys-106 in the recognition peptide. This reaction distorts the conformation of IscU and changes its interaction with HscB, which in turn transmits the change to the nucleotidebinding domain of HscA so as to turn on ATP hydrolysis. The ADP-bound form of HscA interacts with the recognition peptide and stabilizes the D-state of IscU, which releases the Fe-S cluster completely along with HscB. The net result is complete irreversible transfer of the cluster to the acceptor protein. Such a mechanism would have the benefit that ATP hydrolysis is triggered only when an acceptor protein is in place to receive the cluster, thus avoiding idle cycles of ATP hydrolysis and loss of the cluster without transfer.
It has been shown that Hsp70 proteins can disentangle nonnative regions of a misfolded protein and assist folding to its native fold by means of an ATP-dependent cycle (33) (34) (35) . Two mechanisms have been proposed to explain this effect: Hsp70 acts as an "unfoldase" by directly recognizing and unfolding a misfolded protein substrate and then releasing it (36) , and/or Hsp70 acts as a "holdase" that prevents a polypeptide chain from being misfolded or aggregated by holding susceptible regions of the substrate (37) . Our finding that HscA decreases the D 3 S rate and binds to and stabilizes the disordered state of IscU implies that it acts as a holdase, and our finding that HscA has no effect on the S 3 D rate and binds poorly to the structured state of IscU argues against its acting as an unfoldase. A major difference between HscA and the other Hsp70 proteins is that HscA is specifically targeted to the L 99 PPVK 103 motif of IscU, whereas Hsp70 proteins usually have a wide range of substrate specificity. Our chemical shift perturbation study suggests that HscA may have a second recognition motif, V 73 TEWVKG 79 (denoted by an asterisk in Fig. 4B ). We identified signals from IscU in the complex (Fig. 5 ) that appear to correspond to residues directly involved in the binding interaction with HscA. Follow-up studies are under way to assign these signals.
IscU differs from the class of intrinsically disordered proteins that (partially) fold upon binding a protein or other ligand (38) in that the two states (D and S) are nearly equally populated in the absence of ligand. IscU belongs instead to the class of proteins termed metamorphic proteins (39) , which, under physiological conditions, are capable of populating two different folds that fulfill different functions. Founding members of this class include lymphotactin (40, 41) and Mad2 (42) . The two states of metamorphic proteins differ by Ͻ2 kcal/mol. Whereas the alternative states of lymphotactin and Mad2 are monomers and dimers, both states of IscU are monomeric. The co-evolution of stable alternative conformations in metamorphic proteins has yet to be explored in detail.
